In our recent findings, we displayed that the expression of DOK7 was remarkably reduced in clinical breast cancer tissues and the low levels of DOK7 were related to the bad clinical outcomes and prognosis in breast cancer patients. This evidence concerns the gene DOK7 and breast cancer.